Sector › Medicine

Press Releases

Eisai Presents New Findings on Lecanemab's Investigational Subcutaneous Formulation and Modeling Simulation of ApoE4 Genotype on Aria-E Incidence at AAIC 2022

Aug 04, 2022 08:25 HKT/SGT

Eisai and Merck & Co., Inc., Rahway, NJ, USA Provide Update on Phase 3 LEAP-002 Trial

Aug 04, 2022 08:05 HKT/SGT

兆科眼科以NVK002治疗近视加深的第III期临床试验完成患者入组

Aug 03, 2022 10:18 HKT/SGT

兆科眼科以NVK002治療近視加深的第III期臨床試驗完成患者入組

Aug 03, 2022 10:17 HKT/SGT

Zhaoke Ophthalmology Completed Patient Enrollments for the Phase III Clinical Trials of the Myopia Progression Treatment Drug NVK002

Aug 03, 2022 10:16 HKT/SGT

6th Annual ConV2X Telehealth 2022 Event Announced

Aug 01, 2022 21:39 JST

6th Annual ConV2X Telehealth 2022 Event Announced

Aug 01, 2022 20:39 HKT/SGT

Digital Health and Technology Trends in the USA

Aug 01, 2022 10:20 JST

Digital Health and Technology Trends in the USA

Aug 01, 2022 09:10 HKT/SGT

Blockchain in Healthcare Today Journal Announces 2021 Best Article Award

Jul 28, 2022 10:00 JST

Blockchain in Healthcare Today Journal Announces 2021 Best Article Award

Jul 28, 2022 09:30 HKT/SGT

ConV2X Blockchain in Healthcare 2022 Event Announced

Jul 28, 2022 09:00 JST

ConV2X Blockchain in Healthcare 2022 Event Announced

Jul 28, 2022 09:00 HKT/SGT

Hitachi: Proton Therapy Provider Chosen for UW Health Eastpark Medical Center

Jul 27, 2022 15:31 HKT/SGT

노보텍의 유연 근무 정책, 최고 유연 근무 프로그램의 ‘2022년 우수상’ 최종 후보로 선정

Jul 26, 2022 20:00 HKT/SGT

エーザイ、レカネマブのARIA-E発現、皮下注射製剤に関する発表を含むアルツハイマー病／認知症領域の開発品に関する最新データをアルツハイマー病協会国際会議 2022にて発表

Jul 26, 2022 11:30 JST

エーザイ、社会的責任投資指数「FTSE4Good Index Series」の構成銘柄に21年連続で選定

Jul 26, 2022 11:00 JST

Sirnaomics RNAi候选药物STP705用于治疗肝癌的I期临床研究IND申请已获台湾卫生福利部批准

Jul 26, 2022 10:57 HKT/SGT

Sirnaomics RNAi候選藥物STP705用於治療肝癌的I期臨床研究IND申請已獲台灣衛生福利部批准

Jul 26, 2022 10:56 HKT/SGT

Sirnaomics Receives IND Clearance from the Taiwan Ministry of Health and Welfare for Phase I Clinical Study of RNAi Therapeutic STP705 for Liver Cancer Treatment

Jul 26, 2022 10:55 HKT/SGT